BSE Healthcare Index

Curated news coverage, institutional background, regulatory filings, and investigative reporting across RDU Global.

8 Stories Indexed

Last Updated: Just Now

Verified Entity Intelligence

Healthcare, Pharma & Life Sciences Just now (07:19 PM IST)

Medico Remedies Among Five Healthcare Stocks to Hit 52-Week Lows as Sensex Slips 242 Points

Indian healthcare counters came under renewed pressure on Thursday, with five BSE Healthcare Index stocks touching fresh 52-week lows as the Sensex fell 242 points to 72,529. Medico Remedies, Pfizer, AstraZeneca Pharma India, Sanofi Consumer Healthcare India and Eris Lifesciences all marked their weakest levels in a year, underscoring the depth of the sector’s recent correction. Several of these names have now shed as much as 48% in a month, reflecting sustained selling in defensive pockets of the market.

By RDU Global Wire4 min read

Markets, IPOs & Wealth09 Oct 2026, 06:59 PM IST

Cupid Leads Seven BSE 1000 Stocks to Fresh 52-Week Highs as Sensex Surges 879 Points

Seven stocks from the BSE 1000 index touched fresh 52-week highs in a broad-based market rally that lifted the Sensex by 879 points. Cupid emerged as the standout performer with a 31% gain over the past month, while Shreeji Shipping Global and Aditya Infotech also featured among the strongest names on the list.

5 min readRead →

National Governance & Policy12 Nov 2026, 05:00 PM IST

Scientific Research Strengthens India’s Nature-Based Healthcare Push on National Naturopathy Day 2026

India’s nature-based healthcare system is gaining institutional credibility as policymakers and researchers increasingly frame naturopathy as a science-backed complement to mainstream public health. On National Naturopathy Day 2026, the focus has shifted from symbolic recognition to evidence generation, standards, and wider policy integration.

5 min readRead →

Global Economy & Central Banks09 Nov 2026, 05:00 PM IST

Healthcare Stocks Face a Murky Outlook as Congress Tilts Democratic

Healthcare equities are heading into a politically sensitive stretch as Democrats prepare to assume control of Congress, raising the prospect of tougher oversight, renewed pricing scrutiny and a less predictable policy backdrop. Investors are likely to weigh the sector’s defensive appeal against the risk that Washington’s new balance of power could compress margins and limit valuation upside.

4 min readRead →

Healthcare, Pharma & Life Sciences06 Nov 2026, 08:00 PM IST

Tech Is Rewiring Healthcare Into a Faster, Smarter Market

From biosensors and wearables to 3D-printed skin, reconstructed organs and AI-assisted clinical trials, healthcare is entering a technology-led phase that could reshape both patient outcomes and capital markets. The shift is drawing investor attention to companies positioned at the intersection of medtech, biotech and digital health, where scale, regulation and clinical validation will determine winners.

4 min readRead →

Global Markets & Equities05 Nov 2026, 08:00 PM IST

Democrats’ Congress Victory Sets Up a New Fiscal Fight Over Taxes, Healthcare and Household Budgets

Democrats’ capture of Congress marks a sharp turn in Washington and could reshape the financial outlook for households, investors and employers. The party’s agenda is likely to test markets on taxes, healthcare costs, student debt relief and the future of Social Security, while also complicating the policy path for the Federal Reserve and the broader economy.

5 min readRead →

Healthcare, Pharma & Life Sciences02 Nov 2026, 08:00 PM IST

Tech Is Reshaping Healthcare Into a Faster, Smarter Investment Theme

A new wave of health technology is moving from laboratory promise to commercial reality, with sensors, wearables, 3D-printed skin, reconstructed organs and AI-enabled clinical trials drawing growing investor attention. The shift is not only changing how care is delivered, but also how capital is being allocated across medtech, biotech and digital health in India and globally.

5 min readRead →

Global Markets & Equities29 Oct 2026, 05:00 PM IST

GE HealthCare Rises on Broad-Based Growth and Stronger Earnings Outlook

GE HealthCare shares advanced after the company reported results that reinforced the market’s bullish case, with investors focusing on broad-based revenue growth and signs that management’s strategy is gaining traction. The stock’s move reflects confidence that the imaging and diagnostics company is translating operational momentum into a more durable earnings profile.

5 min readRead →

🏢 About this Entity

Corporations, startups, regulatory bodies, central banks, ministries and judicial courts. All news mentioning this entity is automatically verified and aggregated into this live intelligence dossier.

Co-Occurring Entities

Entities frequently referenced alongside BSE Healthcare Index:

Sanofi Consumer Healthcare India(1)Richa Chadha(1)Pfizer(1)New Delhi(1)Musafiri(1)Mumbai(1)